Navigation Links
Sonic Innovations Celebrates 10-Year Anniversary
Date:4/2/2008

fer materially and adversely from those described herein depending on a number of factors including, but not limited to, the following risks: we face aggressive competition in our business; acquisitions could be difficult to integrate and disrupt our current business and therefore may harm our operating results; we may poorly operate newly acquired businesses; we may lose a large customer or suffer a reduction in orders from a large customer; we must have innovative, technologically superior products to compete effectively; our products, due to their complexity, may contain errors or defects that are only discovered after sales by our customers, thus harming our reputation and business; we may have issues with intellectual property; and we have important international operations, which expose us to a variety of risks including government reimbursement, that could impact sales and operating results. For additional information regarding the risks inherent in our business, please see "Factors That May Affect Future Performance" included in our Annual Report on Form 10-K for the year ended December 31, 2007, as filed with the Securities and Exchange Commission.

We undertake no obligation to revise our forward-looking statements to reflect events or circumstances after the date hereof as a result of new information, future events or otherwise.


'/>"/>
SOURCE Sonic Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Sonic Foundry to Host Wisconsin Lt. Governor Lawton in Raising Awareness for National Depression Screening Day
2. Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007
3. Sonic Innovations Not Included in Adverse Jury Verdict
4. Access Innovations Provides Support Services for Agis Network
5. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
6. Prize for Cutting-Edge Laser Innovations
7. Health Literacy Innovations Releases New Survey on Medicaid Health Literacy Standards
8. Cleveland Clinic Unveils Top 10 Medical Innovations For 2008
9. Inverness Medical Innovations Acquires Bio-Stat Healthcare Group
10. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
11. Young Innovations, Inc. Provides Third Quarter Conference Call Details
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...At a symposium today hosted by Johns,Hopkins Uni...earchers presented,the latest research in brain p...science into technology to improve lives. Henry Ma...evidence that cognitive intervention developed by,... brain,s ability to,reorganize itself throughout ...
(Date:12/2/2008)...Newswire/ -- Are you unhappy with your smile but a...vailable? , , The Pennsylvania Dental Assoc...options exist to improve your smile. Your dentist ...o determine a suitable option to help restore your...ntal options. , , , , Tooth wh...
(Date:12/2/2008)...ted for 3.5 percent of high school athletes, injur...y to examine rare injuries and conditions of U.S. ...juries, dental injuries, neck and cervical injurie...lt in high morbidity, costly surgeries and treatme...s associated with the highest rate of rare injurie...
(Date:12/2/2008)...ire/ -- In an open letter to President-elect Barac...s for the Aging (AAHSA) President and CEO Larry Mi...stration can make both short-term gains and develo... its most vulnerable people. , , These fou...rce: Create Jobs in Aging Services; , Construc...
Breaking Medicine News(10 mins):Health News:Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions 2Health News:Cosmetic Dentistry: A Beautiful Smile Is Not Far Away 2
...Barbara Clark, who won the case that allowed her t...atment showed positive signs of recovery from the ...g for four months. But also said that there is a...back. She was diagnosed with HER2-positive breast ...
...An exhaustive genetic study conducted on more than...ysteries associated with earwax. // It could event...e some others have a sticky, brown exudate. The s...ple from either a European or African descent tend...
...Due to shortage of services in a hospital at Brisb...minutes away. Although he was attacked and was in ...e hospital in question is // the Caboolture Hospit...due to shortage of doctors. While the emergency wa...
...WASHINGTON - The Disease Management Association of...ramme that aims to uniformly measure and evaluate ..." "This certainly stands among // the disease ma...search efforts to date,” Don Fetterolf, MD, chair ...
Other Medicine News:Health News:Dry Earwax Mystery Solved: Ear Wax Gene Identified 2Health News:DMAA to Develop Disease Management Standards by December 2
(Date:12/1/2008)...ude study shows the Prox1 gene is a two-way switch... cells to be reprogrammed so that they lose their ...lls , , MEMPHIS, Tenn., Dec. 1 /PRNewswire-...Research Hospital have discovered that a certain d...identity that it requires the constant expression ...
(Date:12/1/2008)...UTH MEETING, Pa., Dec. 1 ...unced that dosing of subjects has begun in study M...ose Phase 1b study of trodusquemine (MSI-1436) in ... a novel therapeutic for the treatment of type 2 d...pherally to regulate insulin and leptin pathways t...
(Date:12/1/2008)...nference Call Scheduled for Tuesday, December 9 at...ML -- , , SOUTH SAN FRANCISCO, Calif., Dec...icals, Inc. (Nasdaq: SNSS ), a biopharmaceutical...ization of new oncology therapeutics, today announ...e myeloid leukemia (AML) will be presented during ...
(Date:12/1/2008)...IEGO, Dec. 1 Vical Incor...ipt of a $1.0 million milestone payment from Merck...on of a Phase I clinical trial of an investigation...e vaccine is based on Vical,s DNA gene delivery te...scriptase (hTERT). hTERT is the subject of separat...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2 26 23163 3B28 5M investment for groundbreaking new research facility 24358 1 26 23163 3B28 5M investment for groundbreaking new research facility 24358 2Study 3A Typhoons bury tons of carbon in the oceans 4184 1Study 3A Typhoons bury tons of carbon in the oceans 4184 2Study 3A Typhoons bury tons of carbon in the oceans 4184 3Study 3A Typhoons bury tons of carbon in the oceans 4184 4The Connecticut Hospice Inc Announces the Arrival of Six Nurse Scholars From The Henrietta Szold Hadassah Hebrew University School of Nursing 24355 1SeQual Technologies American Lung Association of California and Seton Medical Center Partner to Support Survivor 26 Cyclist in 500 Mile California R 24352 1SeQual Technologies American Lung Association of California and Seton Medical Center Partner to Support Survivor 26 Cyclist in 500 Mile California R 24352 2SeQual Technologies American Lung Association of California and Seton Medical Center Partner to Support Survivor 26 Cyclist in 500 Mile California R 24352 3SeQual Technologies American Lung Association of California and Seton Medical Center Partner to Support Survivor 26 Cyclist in 500 Mile California R 24352 4
...ed, the Hutchison Whampoa backed pharmaceutical an...ts for its Phase II,proof-of-concept study for HMP...rm of inflammatory bowel disease. The trial met,i...nd showed an,equivalent drop in clinical symptom s...nt first-line standard of care in,mild-to-moderate...
... Pharmaceuticals (AIM:CEN),("CeNeS" or "the Compan...today announced that a paper published this week i...t a,catechol-O-methyltransferase (COMT) inhibitor ...address profound cognitive,deficits in schizophren...overy programme to develop novel COMT inhibitors. ...
Other Medicine Technology:Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 4Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 5Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 6Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 7Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 8Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 2Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 3Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 4
It has long been a standard requirement for smoke evacuation to be used during laser procedures, however, many in the healthcare industry contend that smoke plume generated from electrosurgical proce
Erbium Laser with Sapphire Erbium Handpiece for Dermatological and Cosmetic Surgery
...e Dornier Medilas D Fibertom is a 60 watt diode co...use of Diode Power Bar technology and 940 nm wavel...ous laser treatment for varicose veins and a varie...m also includes unique safety features including t...
imEXPRESS uses the control panel and setup wizard concept (familiar to any Windows user) allowing you to quickly and easily connect and control your instruments.
Medicine Products: